Key Takeaways: Quitting meth is hard because the drug alters dopamine regulation in the brain, not because of a lack of willpower or personal failure.
Key Takeaways: Meth recovery follows a biological timeline — dopamine transporter levels begin measurable recovery after 12 to 17 months of sustained abstinence, according to
Key Takeaways: Meth relapse rates fall between 40–60%, according to NIDA — statistically comparable to relapse rates for chronic illnesses like diabetes, hypertension, and asthma.
Key Takeaways: Suboxone (buprenorphine/naloxone) is FDA-approved only for opioid use disorder — it does not act on the dopamine pathways that methamphetamine affects, so it
Key Takeaways: Naltrexone is not FDA-approved for methamphetamine use disorder; its use is off-label and best supported by research when combined with bupropion. The ADAPT-2
Key Takeaways: No medication is currently FDA-approved for methamphetamine use disorder — any medication used is prescribed off-label based on clinical research and judgment. The
Key Takeaways: A meth comedown lasts 1–3 days and is generally low-risk, while withdrawal can last 1–2 weeks and carries higher psychological risk, particularly around
Key Takeaways: Meth withdrawal moves through three distinct stages: the crash (days 1–3), acute withdrawal (days 4–10), and subacute withdrawal (weeks 2–10). The crash phase
Key Takeaways: Meth withdrawal symptoms fall into two main categories: physical (fatigue, hypersomnia, increased appetite) and psychological (depression, anxiety, cravings, paranoia), with the psychological symptoms
Key Takeaways: Buckeye, Verrado, and the broader West Valley currently have very limited local access to residential meth detox and treatment, which is why families
Change your life with one call.
You can do it, we can help.
